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The protein Liquid facets (Lqf) promotes endocytosis at the plasma membrane1. 
Lqf activity is required for proper Notch signaling, likely through facilitating the 
endocytosis of Notch ligand by indirectly linking ligand to clathrin. A genetic modifier 
screen to identify genes that interact with lqf was performed by a previous graduate 
student. Genes identified in the screen might provide new insights into how Lqf 
promotes endocytosis or how Notch signaling is regulated. In this work, I performed 
genetic mapping techniques to identify the genes mutated in each complementation 
group of the screen. I identified the gene mutated in complementation group 6 as 
mitochondrial alanyl tRNA synthetase (Aats-ala-m). tRNA synthetases link a tRNA to its 
cognate amino acid during translation. Mitochondrial tRNA synthetases function in the 
mitochondria in translation. Aats-ala-m genetically interacts with lqf, suggesting the two 
genes function in the same pathway. In this work, I also identified chromosomal regions 
where the genes mutated in complementation groups 1,2, and 9 are located. 
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Chapter 1: Introduction 
Notch signaling in development 
Notch signaling is a conserved pathway throughout the animal kingdom and 
functions in a diverse set of cellular contexts. Notch signaling plays a part in cell fate 
determination during organism development by mediating communication between 
adjacent cells. In Notch signaling, Notch receptor on the plasma membrane is activated 
through the interaction between the receptor and Notch ligand of the DSL family on the 
membrane of an adjacent cell. Differences in the strength of signal sending and 
receiving between the two cells lead to one cell adopting a signal sending fate and the 
adjacent cell having a signal receiving fate. The cells will then take separate lines of 
differentiation. 
 
Mechanism of Notch signaling 
Notch receptor at the plasma membrane is a heterodimer composed of an 
extracellular N-terminal fragment and transmembrane/intracellular C-terminal 
fragment3. Interaction with ligand on an adjacent cell leads to two cleavages of the 
Notch receptor. The second cleavage by the γ-secretase complex generates the Notch 
intracellular domain (NICD)3. NICD translocates to the nucleus where it promotes 
transcription of Notch target genes, in association with the DNA binding proteins 
Suppressor of Hairless Su(H) and Mastermind (Mam)4. 
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Endocytosis of the ligand is required in Notch signal sending for activation of the Notch 
receptor. One model is that endocytosis of ligand generates a pulling force that exposes 
a protease cleavage site on the Notch receptor3. The Drosophila Epsin Lqf is involved in 
endocytosis of ligand. Fat facets (Faf) deubiqutinates Lqf, leading to stabilization of Lqf5. 
Endocytosis of ligand is promoted by the E3 ligases Neuralized and Mindbomb, which 
ubiquitinate ligand6. Endocytosis is also required in the signal receiving cell for proper 
Notch signaling. It is not known why endocytosis is required in the receiving cell3. 
 
Lqf in development 
Lqf is required in Notch signaling in Drosophila in the signal sending cell. It is 
likely that Lqf is involved in all Notch signaling events throughout the organism1. At the 
N-terminus, Lqf has an Epsin-N-terminal homology (ENTH) domain which binds PIP2 
(phosphatidylinositol4,5-bisphosphate) at the plasma membrane1. Lqf has two Ubiquitin 
interaction motifs (UIMs) which are required for ubiquitination of Lqf and mediate the 
interaction between Lqf and ubiquitaned proteins. There are two Clathrin binding motifs 
(CBMs) on Lqf which allow Lqf to bind to clathrin. Also, Lqf has seven DPW motifs and 
two NPF motifs. The DPW motifs promote binding of Lqf to AP-2, and the NPF motifs 
promote binding to endocytic factors containing an EH (Eps15-homology) domain. A  
model for how Lqf promotes endocytosis of ligand is that Lqf associates with 
ubiquitinated ligand at the plasma membrane and associates with clathrin binding 
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endocytic factors such as the AP-2 complex, thereby indirectly linking ligand to clathrin1. 
Lqf is also involved in promoting curvature of the plasma membrane7. 
 Lqf is involved in cellular events other than endocytosis and Notch signaling. The 
two yeast lqf homologs, ENT1 and ENT2 interact through the ENTH domain of these 
proteins with GTPase activating proteins (GAPs) of Cdc42, a regulator of the actin 
cytoskeleton2. In human cells, the Lqf homolog Epsin 1 associates with ubiquitinated 
EGF Receptor (EGFR) and promotes internalization of EGFR8. 
 
Endocytosis 
Clathrin mediated endocytosis (CME) is a process that occurs at the plasma 
membrane where vesicles form that are coated with a complex set of proteins including 
clathrin, and are then internalized into the cytoplasm9. In CME, at the site of a forming 
clathrin coated vesicle, clathrin is linked to a receptor within the plasma membrane by 
an adaptor protein such as AP2. Dynamin at the neck of the forming vesicle pinches the 
vesicle from the plasma membrane9. Hsc70, with the assistance of Auxilin, uncoats the 
adaptor proteins and clathrn from the clathrin coated vesicle. The vesicle then fuses 
with an early endosome. Additional proteins such as Rab5, Avl, Hrs, and Rab11 mediate 
endosomal sorting. The contents of the vesicle traffic to the late endosome and  





Chapter 2: Results 
A screen was performed by Ben Dolan to identify genes that interact with lqf (fig. 
1). Bomsoo Cho performed complementation testing of the alleles isolated in the screen 
and found that the alleles group into 9 complementation groups, based on the 
observation that combinations of the alleles cause lethality. Bomsoo performed meiotic 
mapping of alleles from all complementation groups, and found that the Neuralized 
gene is mutated in group 3, C-terminal Src Kinase (Csk) is mutated in group 4, and trio is 
mutated in group 7. For several the remaining complementation groups, Bomsoo also 
found deficiencies that failed to complement the lethality of the alleles from the screen. 
I set out to identify the genes mutated in complementation groups 1,2,5,6,8, and 9. 
 
Group 1 
 Meiotic mapping results suggested that the gene mutated in group 1 is located 
between the markers stripe (sr) and ebony (e) on the right arm of chromosome three. 
There are four group 1 alleles, 04, G7, S2, and J12. I carried out deficiency mapping to 
identify the chromosomal region containing the mutant gene. If the mutant gene is 
within the breakpoints of a deficiency, it is expected that a fly carrying one third 
chromosome copy of the deficiency and one third chromosome with an allele of the 
mutant gene would not be viable, since a proper level of gene product is required for 
viability. I performed crosses between lines of flies with alleles of the gene to flies 
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containing molecularly mapped deficiencies which remove portions of DNA between sr 
and e, and analyzed phenotypes to determine if deficiency/group 1 allele flies were 
present in the progeny of the cross. I found that bsc516 causes a lethality phenotype in 
combination with 04, G7, S2, and J12 (fig. 2). Bsc141 causes a lethality phenotype with 
G7 and S3. bsc124 is viable in combination with all four alleles. From the mapping 
results, the Group 1 gene is likely between the 5’ breakpoint of bsc141, and 5’ 
breakpoint of bsc124, between 16,420,602 and 16,561,028. There are 13 genes in this 
region. bsc141/O4 flies have an escaper phenotype, meaning that there is a reduced 
number of viable flies of this genotype in the F1 generation of the cross compared to 
the expected number of flies. It is not clear why 04 is non-viable in combination with 
bsc516 but has an escaper phenotype in combination with bsc141. One explanation for 
why 04 is lethal with bsc516 but not bsc141 is that bsc141 may partially delete the 
group 1 gene, or disturb a regulatory region of the gene, while bsc516 completely 
deletes the gene. It is possible that the Group 1 gene is slightly upstream of the 5' 
breakpoint of bsc141. Alternatively, the group 1 gene may be within the region deleted 
by both bsc516 and bsc141, and the bsc516 deletion in combination with O4, like 
bsc141, causes only a reduction in viability, but extraneous factors such as the genetic 
background of one of the chromosomes enhances the reduced viability to lethality.  
 I next attempted to identify the Group 1 gene by complementation testing of 
alleles of genes in the region with the group 1 alleles. Alleles of the group 1 gene are  
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homozygous lethal, and lethal in transheterozygous combination. This suggests that 
reduced protein levels of the group 1 gene result in lethality. If an allele of a gene in the 
region identified by deficiency mapping results in reduced protein levels of the gene, 
and I find that the allele is lethal in transheterozygous combination with the group 1 
alleles, this would suggest that this is the gene that is mutated in complementation 
group 1. I obtained alleles of 7 of the genes in the region that contains the mutant gene 
(table 1). To determine if the alleles result in reduced protein activity of each gene, I 
tested if each allele is lethal in transheterozygous combination with bsc516. bsc516 
completely overlaps all seven genes, so there should be no gene product from any of 
the seven genes from a bsc516 chromosome. Assuming that the gene is required for 
viability, if bsc516/allele flies are non-viable, this would suggest that the allele of the 
gene results in a decrease in levels of the protein encoded by the gene below a level 
required for viability. I found that flies transheterozygous for bsc516 and alleles of six of 
the genes are non-viable (table 1), suggesting that each allele causes reduced protein 
levels of the gene. I found that flies transheterozygous for each allele and alleles of the 
group 1 gene are viable. This suggests that the group 1 gene is not one of the genes  
tested by complementation testing. The group 1 gene is likely one of the six genes not 
tested by complementation testing, or a gene that is deleted in bsc516, but upstream of 
the 5’ breakpoint of bsc141.   
 lqfFDD9 is a hypomorphic, temperature sensitive allele of lqf. lqfFDD9 homozygous  
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flies are viable and have phenotypes due to loss of Notch signaling in the eye, wing, and 
leg tarsal segment10. lqfFDD9 J12/lqfFDD9 flies are non-viable. This might mean that proper 
group 1 gene activity is important for lqf function. 
 
Group 2 
I set out to identify the gene mutated in complementation group 2. There are 
two group 2 alleles, F1 and S5. Flies that are triply heterozygous for fafBX4, lqfFDD9, and F1 
or S5 have rough eyes (fig. 3). Since there is a strong requirement for proper levels of all 
three proteins, this might mean that lqf, faf, and the group 2 gene are closely involved in 
a common biological process. 
The gene mutated in group 2 was mapped between hairy (h) and curled (cu). 
Bomsoo Cho performed mapping with deficiencies and found that Df(3R)Me15 fails to 
complement the lethality of complementation group members F1 and S5. I obtained 
deficiency mapping results which suggested that the mutant gene did not map to the 
region deleted by Df(3R)Me15 (fig. 4) and found that the deficiency does not exist on 
the chromosome listed as Df(3R)Me15 (fig 5). I then tested if the gene is located in other 
regions between h and cu. 61 molecularly mapped deletions in this region were tested 
to determine if they fail to complement the lethality of F1 and S5. I found that ed4685 
fails to complement both complementation group members. I then found that bsc414, 
bsc432, and ex6131, which either partially or completely overlap ed4685, fail to  
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complement F1 and S5 (fig. 6). These results allowed me to narrow down the region 
containing the gene to 3L:17231345-17332971. There are nine genes within this region 
(fig. 7). 
 I sequenced the DNA of cg7707, cg13723, cg6485, and cg6479 from the alleles 
F1 and S5 and did not find a mutation. This result suggests that the gene mutated in 
group 2 is not one of these genes. I performed complementation testing to determine if 
the group 2 gene is cg6512. The cg6512EY04074 allele is a P{EPgy2} insertion in the 5’ UTR 
of cg6512. cg6512EY04074 fails to complement the lethality of an overlapping deficiency. 
This suggests that the cg6512EY04074 allele causes a decrease in protein activity of 
Cg6512. Flies that are transheterozygotes for cg6512EY04074 and alleles of the group 2 
gene are viable. This suggests that the group 2 gene is not cg6512.  
 Most likely, the group 2 gene is cg6497, cg13724, cg13725 or Odorant receptor 
74a (Or74a). cg6497, cg13724, and cg13725 have no known conserved domains. Or74a 
is a member of a family of 60 odorant receptor genes in Drosophila11. Odorant receptors 
are 7 pass transmembrane G-Protein coupled receptors (GPCRs) that bind to odorant 
molecules and elicit a neuronal response. Except for cg13724, cDNA and EST evidence 
suggests that these are functional genes.  
 Alternatively, it is possible that the group 2 gene is not cg6497, cg13724, 
cg13725, or Or74a. The group 2 gene may be cg6512. The cg6512EY04074 allele is lethal in 
combination with deficiency, presumably because Cg6512 protein levels fall below a  
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level required for viability. F1 and S5 may be alleles of cg6512 that have some residual 
Cg6512 protein activity, and if cg6512EY04074  has some residual protein activity, there 
may be enough protein activity for flies that are tranheterozygous for cg6512EY0407412 
and alleles F1 and S5 to be viable. cg6512 encodes a mitochondria targeted protein. 
cg6512 bares sequence similarity to human AFG3-like protein 2. AFG3-like protein 2 is 
part of a protease complex on the inner-membrane of the mitochondria12. It is also 
possible that the group 2 gene is located slightly upstream of the 5' breakpoint of 
ex6131. ex6131/F1 or S5 flies might be lethal because transcription of the group 2 gene 
is disrupted by ex6131. The 5’ breakpoint of ex6131 comes close to the transcription 
start site of RNA binding protein 6 (Rbp6), a gene with large intronic sequences that 
encompasses 170kb. It is possible that Rbp6 is the group 2 gene. A third possibility is 
that the group 2 gene is within the 3L:17231345-17332971 region, but it has not been 
identified as a gene.  
 
Group 5 
Complementation group 5 contains fourteen alleles. Bomsoo Cho performed 
meiotic mapping, and the results suggested that the mutant gene is located between  
the marker ebony and the telomere, on the right arm of the third chromosome. Bomsoo 
performed mapping with 22 Exelixis deficiencies, and found that ex6210 is lethal or 
causes a reduced viability phenotype in combination with several of the Group 5 alleles.  
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I found that a deficiency which partially overlaps ex6210, bsc567, also is lethal or causes 
a reduced viability phenotype in combination with several of the Group 5 alleles. 
However, deficiencies overlapping bsc567 and ex6210 were viable in combination with 
group 5 alleles. This result suggested that the gene mutated in group 5 was somewhere 
else between ebony and the telomere. Juan Raudales and I performed mapping with 
deficiencies in regions telomeric to ebony that were not originally tested by Bomsoo 
(table 2).  No deficiencies were found to be lethal with the complementation group 5 
alleles. There are regions between ebony and the telomere that are not uncovered by 
deficiencies, and it is likely that the gene mutated in group 5 is in one of these regions. 
 
Group 6 
 I also set off to identify the gene mutated in complementation group 6. Group 6 
contains alleles S1 and B1, which are homozygous lethal. The S1/B1 transheterozygote is 
lethal, and heterozygous mutation of S1 or B1 enhances the lqfFDD9 eye phenotype (fig. 
8). Bomsoo found that the group 6 gene maps between ru and h on the left arm of 
chromosome 3, and found that flies that are transheterozygous for deficiencies ed210 
and ex6103 are non-viable in combination with the group 6 alleles (fig. 9) and flies  
transheterozygous for ex6104 and the group 6 alleles are viable. I found that 
deficiencies bsc557, bsc371, and bsc372 in combination with alleles S1 and B1 cause 
lethality (fig. 9). From this result, I narrowed down the region containing the mutation  
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to 3L:5129360..5177896. The PBac{SAStopDsRed} element is designed to generate loss 
of function mutations in genes where an insertion of the element occurs by splicing a 
stop codon into the open reading frame of the gene13. The PBac{SAStopDsRed}LL05514 
line has an insertion of the element in the third intron of the Aats-ala-m gene. I found 
that flies transheterozygous for PBac{SAStopDsRed}LL05514 and S1 or B1 are non-
viable. This suggests that Aats-ala-m is the gene mutated in group 6. 
PBac{SAStopDsRed}LL05514 is also lethal with overlapping deficiencies. The identity of 
the complementation group 6 gene as Aats-ala-m was confirmed by my finding that 
expression of wild-type Aats-ala-m cDNA rescues the lethality seen in combinations of 
alleles B1, S1, and PBac{SAStopDsRed}LL05514 (fig. 10). Sequencing of the mutant 
chromosomes showed that the Aats-ala-mS1 allele is a nonsense mutation that 
introduces a stop codon at amino acid 9 (fig. 11). The Aats-ala-mB1 allele is a missense 
mutation at amino acid 53 that changes a glycine to aspartic acid within the active site 
(fig. 12).  
 Phylogenetic analysis suggests that the gene I identified encodes the Drosophila 
mitochondrial alanyl tRNA synthetase. The Aats-ala-m sequence shows similarity to 
mitochondrial alanyl tRNA synthetases from other species14. Further support for the 
idea that the gene is a mitochondrial tRNA synthetase is that the protein encoded by  
Aats-ala-m aminoacylates mitochondrial-tRNAala in vitro15. 
 Aminoacyl tRNA synthetases (Aats) link an amino acid to its cognate tRNA during 
protein translation. Most organisms have two nuclear encoded Aats genes for a given  
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amino acid. One Aats is involved in aminoacylation in the cytoplasm and the other 
aminoacylates in the mitochondria. Aminoacyl-tRNA synthetases often have cellular 
functions in addition to their role in aminoacylation. They are involved in a range of 
cellular processes including apoptosis16, cytokine signaling17, and translational 
silencing18. Mitochondrial aminoacyl-tRNA synthetases play a role in splicing of 
mitochondrial Group 1 and 2 introns19. 
 
Group 8 
The gene mutated in group 8 was mapped meiotically between ru and h. 
Stephen Fleenor performed complementation testing using deficiencies between ru and 
h, and did not find any deficiencies that were lethal in combination with group 8 alleles 
G6 and K7 (table 3). These deficiencies did not uncover the entire region between ru 
and h.  Juan Raudales performed complementation testing using deficiencies that 
uncovered regions not previously tested, and did not find any deficiencies that were 
lethal in combination with group 8 alleles. In addition, I performed complementation 
testing with deficiencies and did not find any that were lethal with group 8 alleles. There 
are regions of DNA between ru and h not uncovered by any deficiencies, and the group  





              The gene mutated in group 9 was mapped between h and cu. Bomsoo found 
deficiencies 81k19 and ex6130 were lethal in combination with complementation group 
members J12 and 05 (fig. 13).  I performed additional complementation testing with 
deficiencies in the region. I found that ed223 is lethal in combination with 05 and J12, 
ed4674 is lethal in combination with 05 and J12, ex9002 is lethal in combination with 
J12 and viable with O5, ed4606 is viable with 05 and J12, and bsc561 and ex9004 are 
viable with both O5 and J12. The most likely explanation for these results is that the 
gene mutated in complementation group 9 is located in the region from the 3' end of 
ed4606 to the 3' end of ex6130, between 16,773,223 and 16,799,748. ex9002 may be 
lethal in combination with J12 but not O5 if J12 is a stronger allele than O5, and the 
deletion disturbs a regulatory region of the group 9 gene and is a hypomorphic allele of 
the gene.  
 The complementation group 9 gene is likely one of the four genes located in the 
16,773,223 and 16,799,748 region. cg9674 encodes a protein with sequence homology 
to the glutamate synthase family of genes. Glutamate synthases are present in bacteria, 
plants, and insects and catalyze the synthesis of glutamate from glutamine and 2-
oxoglutarate20. Int6 is a subunit of Eukaryotic translation initiation factor 3 and also a  
regulator of the proteasome21. cg9706 is the Drosophila member of the Acetyl-
CoenzymeA transporter family22. Acetyl-CoenzymeA transporters are transmembrane 
proteins of the Endoplasmic Reticulum (ER) that transport acetyl Coenzyme A into the  
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lumen of the ER/Golgi Apparatus. Acetyl Coenzyme A is used in the Golgi for O-
acetylation of proteins, a form of post-translational processing. cg9705 has a nucleic 
acid binding domain (flybase.org). 
 
 
Figure 1.  lqfFDD9 genetic modifier screen performed by Ben Dolan 
 
 
Figure 2. Group 1 deficiency mapping results.  
The tan bars represent deficiency/allele combinations that are non-viable, and the green 





Figure 3. Triple heterozygotes display a rough eye phenotype 
 
 
Figure 4. Deficiency mapping around the region deleted by Df(3R)Me15.  
The exact sequence coordinates of Df(3R)Me15  are not known. Df(3R)Me15 was 
mapped to this region by complementation testing. Overlapping deficiencies generally 
complemented the lethality of F1 and S5. This suggests that the gene mutated in 




Figure 5. Complementation  testing suggests deficiency is not present 
The genes hkb, tacc, and hd are required for viability. Previous groups showed that flies 
transheterozygous for alleles of hkb and Df(3R)ME15, and tacc and Df(3R)ME15 are non-
viable, suggesting the deficiency removes the chromosomal region containing hkb and 
tacc. Complementation testing that I performed suggests that the deficiency is not 
present on the Df(3R)ME15 chromosome stocked in our lab. The genes listed are: 
huckebein (hkb), transforming acidic coiled-coil protein (tacc), humpty dumpty (hd), tube 
















Figure 8.  B1 and S1 alleles enhance the lqfFDD9 rough eye phenotype 
 




Figure 10. Expression of WT Aats-ala-m cDNA resuces lethality of group 6 alleles 
Aats-ala-mS1/Aats-ala-mB1, Aats-ala-mS1/Aats-ala-mPBac{SAstopDsRed}LL05514, and Aats-ala-
mB1/Aats-ala-mPBac{SAstopDsRed}LL05514 flies are non-viable. Expression of wild type Aats-ala-















Figure 11.  
The screen was performed in an isogenized background, so differences between DNA 
sequences between different alleles generated in the screen likely arose due to EMS 
mutagenesis events. A.) Sequence trace from the B1 allele from 3L: 5139302 to 
5139335. This sequence is identical to the sequence from Drosophila of genotype y; cn 
bw sp from the Drosophila Genomic Sequencing Project
26
. 
B.) Sequence trace from the S1 allele from 3L: 5139302 to 5139335. There is a change at 







A.) Sequence trace from the S1 allele from 3L: 5139436 
 to 5139469. This sequence is identical to the sequence from Drosophila of genotype y; 
cn bw sp from the Drosophila Genomic Sequencing Project. 
B.) Sequence trace from the 131 allele from 3L: 5139436 to 5139469. There is a change 









Table 1. Complementation testing to identify the group 1 gene 
Each allele likely results in reduced activity of the protein encoded by the gene, since 
the alleles are non-viable in combination with bsc516. Each allele is viable in 
combination with alleles from the screen, suggesting the group 1 gene is likely not one 
of the seven genes listed in the table. The Neprilysin 4 allele was not tested for lethality 
in combination with bsc516, but it is likely a loss-of-function allele, since the PBac 





Table 2. Deficiency mapping to identify the group 5 gene 
















Chapter 3: Discussion 
In this work, I identified Aats-ala-m as a gene that interacts with lqf. This result 
likely means that lqf and Aats-ala-m interact in a common genetic pathway. It is possible 
that Aats-ala-m interacts with Lqf through a Notch signaling related activity of Lqf or an 
activity of Lqf not related to Notch signaling. How might Aats-ala-m interact with lqf? 
Aats-ala-m might interact with Lqf through its role in translation in the mitochondria. 
Decreased mitochondrial translation in Aats-ala-m mutants might lead to decreased 
levels of proteins of the electron transport chain, and decreased cellular ATP and GTP.  A 
certain cellular process related to Lqf function might be highly energy dependent, and 
Aats-ala-m and lqf genetically interact because Aats-ala-m is required to maintain 
proper energy levels required for this process. It is also possible that Aats-ala-m 
mutation causes a reduction in ATP levels which disrupt many cellular processes, 
including functions of Lqf. Alternatively Aats-ala-m might have an extra-mitochondrial 
function in the cell in addition to its mitochondrial activity, and Aats-ala-m interacts with 
Lqf through the secondary function. 
 Additional findings were that I identified narrow chromosomal regions 
containing the genes mutated in complementation groups one, two, and nine. 
Additional work, especially sequencing candidate genes from alleles of the 
complementation groups, would likely lead to the identification of the genes mutated in 
these groups.  
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Chapter 4: Materials and Methods 
Fly Crosses 
All fly crosses were carried out at 25○ C. 
 
Sequencing the S1 allele 
For the S1 allele, I generated a fly stock of the genotype: S1, lqfFDD9/TM6B, GFP.   
S1, lqfFDD9/TM6B, GFP flies were put in a container with a petri-dish of solid agar-apple 
juice, and the flies laid eggs on the petri dish. S1, lqfFDD9 homozygous first instar larvae 
were collected using a microscope projecting UV light, by virtue of the fact that these 
larvae lack GFP expression. Larvae were collected and homogenized with a mortar and 
pestle in squishing buffer: 10 mM Tris-HCl pH8, 1 mM EDTA 25 mM NaCl, 200 µg/mL 
Proteinase K. I used 1 larvae per 10 µL squishing buffer. Once homogenized, the larvae 
were incubated at 37○ C for 3o minutes, and 95○ C for 2 minutes. I performed PCR to 
amplify regions of the Aats-ala-m gene from this DNA. Three PCR products were 
generated, using three different sets of primers, corresponding to the beginning, 
middle, and end parts of the Aats-ala-m gene. Once I obtained PCR product, I cloned the 
PCR product into the pCR-Blunt II-TOPO vector using the Invitrogen Zero Blunt TOPO 
PCR cloning kit. The vector containing PCR product was transformed into E. Coli, and I 
plated the transformed E. Coli onto LB plates containing Kanamycin. Colonies on the 
plates were of bacteria that were transformed with the vector-PCR product, since the 
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vector contains Kanamycin resistance. I then grew the transformed bacteria in liquid LB, 
and used a phenol-chloroform plasmid isolation protocol to isolate the vector-PCR 
product. I sequenced the PCR product from the vector using M13 Reverse and T7 primer 
sites located within the vector. For the Aats-ala-m middle and end part PCR products, 
the entire PCR products were sequenced, and I did not find any mutations when the 
sequenced DNA was compared to the Drosophila sequences by BLAST alignment, or the 
DNA sequences from the 131 allele (described below). For the Aats-ala-m beginning part 
PCR product, several separate PCR reactions were carried out, and the PCR products 
were individually transformed and sequenced. Each sequencing result showed the 
mutation at 5139319. 
 
Sequencing the 131 allele 
I was not able to obtain lqfFDD9 131 homozygous larvae, so I obtained DNA from 
131 homozygous flies in another way. I generated flies that were of the genotype: 
Act5c-Gal4/UAS-Aats-ala-m-cDNA; Aats-ala-m131/Aats-ala-m131. These flies live to the 
adult stage. I obtained DNA from adults of this genotype and carried out PCR reactions 
to amplify the beginning, middle, and end parts of Aats-ala-m. The PCR reactions should 
only amplify DNA from the third chromosome, and not from the UAS-Aats-ala-m-cDNA 
rescue construct, since the primers for the PCR reaction are designed towards Aats-ala-
m intronic sequences, or sequences outside the Aats-ala-m gene region. The PCR  
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product was sequenced directly using the PCR primers. I sequenced the entire Aats-ala-
m middle and end part PCR products and did not find a mutation in these regions. For 
the Aats-ala-m beginning part, I sequenced PCR product from two separate PCR 
reactions. Both sequencing results yielded the 5139452 mutation. 
 
Generating UAS-Aats-ala-m-cDNA rescue construct 
I obtained LD11251, which is Wild-Type Aats-ala-m cDNA contained within the 
pBluescript SK- vector. I transformed LD11251 into E. Coli and obtained a culture of E. 
Coli containing LD11251. I grew this culture of E. Coli and performed a mini-prep to 
purify LD11251. Once purified, I excised the cDNA insert from pBluescript using NotI and 
KpnI restriction enzymes. I restricted the pUAST vector with NotI and KpnI and ligated 
the insert into pUAST. I transformed pUAST-Aats-ala-m-cDNA into E. Coli and obtained 
cultures containing pUAST-Aats-ala-m-cDNA. I purified pUAST-Aats-ala-m-cDNA by midi-
prep. I performed sequencing of pUAST-Aats-ala-m-cDNA to assure that I generated the 
correct vector-insert. Drosophila were transformed with pUAST-Aats-ala-m-cDNA by 
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